BPMC Chart
- 52-Week Range: $51.85 - $115.99
- Market Capitalization: $3.47B
- Short Percentage: 0%
- Target Price: $103.71
- Shares Outstanding: 59.57M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
BPMC released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PRNewsWire | April 6th
- Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PRNewsWire | March 4th
- Blueprint Medicines' (BPMC) CEO Jeff Albers on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 16th
- Blueprint Medicines Elevates Two Talented Leaders to its Executive TeamPRNewsWire | January 20th
- Blueprint Medicines Appoints Daniella Beckman to its Board of DirectorsPRNewsWire | December 9th
Company Info
Website: https://www.blueprintmedicines.com
Address: 45 Sidney Street, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 495
Address: 45 Sidney Street, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 495
$BPMC soon
$BPMC Bull trap
$BPMC Shorts are calling in all the favors
$BPMC day trade is ok to buy here but sell later
$BPMC hold
$BPMC LFGGGGGG
$BPMC Hedgies
we aren't going anywhere!
$BPMC time to short this
$BPMC green shoots
$BPMC getting this mare ready to run today